4.76
Finanzdaten der Abeona Therapeutics Inc-Aktie (ABEO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.40 | - | - | - |
|
|
3.56%
24.02
|
23.19 | 19.73 | 16.67 | 15.35 |
| Interest Income/Expense |
5.85%
0.901
|
0.957 | 0.998 | 1.082 | 1.102 |
| Benefits Costs and Expenses |
116.43%
20.36
|
-123.94 | 12.03 | - | - |
| Costs And Expenses |
3.56%
24.02
|
23.19 | 19.73 | - | - |
| Depreciation and Amortization |
0.00%
0.60
|
0.60 | 0.50 | 0.50 | 0.50 |
| Operating Income/Loss |
5.38%
-24.02
|
-22.79 | -19.73 | -16.67 | -15.35 |
| Nonoperating Income/Loss |
44.94%
0.129
|
0.089 | 0.141 | 0.663 | 0.145 |
| Income/Loss From Continuing Operations Before Tax |
116.37%
-20.36
|
124.34 | -12.03 | -9.293 | -30.27 |
| Income Tax Expense/Benefit, Current |
1.94%
15.20
|
15.50 | -30.40 | - | - |
| Income Tax Expense/Benefit |
1.94%
15.20
|
15.50 | -30.40 | - | - |
| Income/Loss From Continuing Operations After Tax |
132.67%
-35.56
|
108.84 | -12.03 | -9.293 | -30.27 |
|
|
104.74%
-5.161
|
108.83 | -12.03 | -9.293 | -30.27 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | -0.029 | 0.007 | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3.27%
54.24
|
52.52 | 49.78 | 2.5439 | 48.08 |
| Diluted Average Shares |
18.60%
54.24
|
66.64 | 49.78 | 2.5439 | 48.08 |
| Basic Earnings Per Share |
104.83%
-0.10
|
2.07 | -0.24 | -0.14 | -0.63 |
| Diluted Earnings Per Share |
105.85%
-0.10
|
1.71 | -0.24 | -0.14 | -0.63 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | -0.029 | 0.007 | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):